內(nèi)分泌腺來(lái)源血管內(nèi)皮生長(zhǎng)因子(EG-VEGF)活性蛋白
Active Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
PK1; EGVEGF; PRK1, PROK1; Prokineticin 1; Black Mamba Toxin-Related Protein; Mambakine
- 編號(hào)UAPA024Hu01
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 緩沖液成份20mM Tris, 150mM NaCl緩沖液（pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300）
- 性狀凍干粉
- 純度> 90%
- 等電點(diǎn)8.1
- 應(yīng)用Cell?culture;?Activity?Assays.
- 下載 英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 ¥ 634 ¥ 1584 ¥ 3168 ¥ 9504 ¥ 23760
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷(xiāo)商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Figure. SDS-PAGE
-
Figure. Western Blot
-
通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
活性實(shí)驗(yàn)
Figure 1. Cell proliferation of ECV-304 cells after stimulated with EG-VEGF.
Endothelial gland-derived VEGF (EG-VEGF) is an angiogenic protein that is structurally unrelated to VEGF. It is expressed in steroidogenic tissues such as adrenal gland, ovary, testis, and placenta. Like VEGF it can induce fenestrae in endothelial cells. To test the effect of EG-VEGF on cell proliferation of ECV-304 endothelium cell line, cells were seeded into triplicate wells of 96-well plates at a density of 5,000 cells/well and allowed to attach overnight, then the medium was replaced with serum-free standard DMEM?prior to the addition of various concentrations of EG-VEGF. After incubated for 72h,?cells were observed by inverted microscope and cell proliferation was measured by Cell Counting Kit-8 (CCK-8). Briefly, 10μL of CCK-8 solution was added to each well of the plate, then measure the absorbance at 450nm using a microplate reader after incubating the plate for 1-4 hours at 37℃.
(A) Unstimulated ECV-304 cells cultured in 1640 for 96h;
(B) ECV-304 cells cultured in 1640, stimulated with 10ng/mL VEGF121 for 96h.
Figure. Cell proliferation of ECV-304 cells after stimulated with EG-VEGF
用法
Reconstitute in 20mM Tris, 150mM NaCl (PH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月，-80°C不超過(guò)12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| URPA024Hu01 | 內(nèi)分泌腺來(lái)源血管內(nèi)皮生長(zhǎng)因子(EG-VEGF)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UAPA024Hu01 | 內(nèi)分泌腺來(lái)源血管內(nèi)皮生長(zhǎng)因子(EG-VEGF)活性蛋白 | Cell?culture;?Activity?Assays. |
| UPAA024Hu01 | 內(nèi)分泌腺來(lái)源血管內(nèi)皮生長(zhǎng)因子(EG-VEGF)多克隆抗體 | WB; IHC; ICC; IP. |
| UMAA024Hu22 | 內(nèi)分泌腺來(lái)源血管內(nèi)皮生長(zhǎng)因子(EG-VEGF)單克隆抗體 | WB; IHC; ICC; IP. |
| USEA024Hu | 內(nèi)分泌腺來(lái)源血管內(nèi)皮生長(zhǎng)因子(EG-VEGF)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| USCA024Hu | 內(nèi)分泌腺來(lái)源血管內(nèi)皮生長(zhǎng)因子(EG-VEGF)檢測(cè)試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| ULMA024Hu | 內(nèi)分泌腺來(lái)源血管內(nèi)皮生長(zhǎng)因子(EG-VEGF)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Tumor Biology | Hypoxia-induced secretion of IL-14 from adipose-derived mesenchymal stem cell promotes growth and cancer stem cell properties of Burkitt lymphoma [PubMed: 26695151] |
| Stem?Cells?and Development | Lower Senescence of Adipose-Derived Stem Cells than Donor-Matched Bone Marrow Stem Cells for Surgical Ventricular Restoration [Pubmed:29630447] |
